Xing Zhang

10PUBLICATIONS
34CO-AUTHORS
Molecular targetsSolid tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|Nov 24, 2024
Neoadjuvant immunotherapy in the evolving landscape of sarcoma treatment.

Qiyan Cai, Yi Que, Xing Zhang

|Oct 10, 2024
Targeting KIFC1 Promotes Senescence in Soft Tissue Sarcoma via FXR1-Dependent Regulation of MAD2L1 mRNA Stability.

Xiu-Xia Lu, Yi Que, Jing Yang

|Aug 25, 2024
FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma.

Wei Xiao, Liping Xu, Jinghua Wang

|May 15, 2023
Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade.

Dong-Chun Hong, Jing Yang, Cong Sun

|Mar 03, 2022
Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.

Wanming Hu, Li Yuan, Xinke Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Wei Xiao

1 joint publications

Jingjing Li

1 joint publications

Qiu-Zhong Pan

1 joint publications

Xinke Zhang